$Conduit Pharmaceuticals (CDT.US)$ Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
GlobeNewswire· 5 mins ago
Approval of composition of matter patent in key jurisdiction underscores the Company's commitment to maximize future out-licensing value

Hi mooers!
$PDD Holdings (PDD.US)$ is releasing its Q3 earnings on November 21 before the bell. Unlock insights with PDD Earnings Hub>>
$PDD Holdings (PDD.US)$' share prices often fluctuate a lot around earnings releases, like the +18.08% jump after 2023 Q3 earnings, and the -28.51% drop after 2024 Q3 earnings results. Amid recent economic stimulus policies from the Chinese government, how would this famous Chinese e-commerce co...

$PDD Holdings (PDD.US)$
PDD Holdings Q3 2024 earnings conference call is scheduled for November 21 at 7:30 AM EDT /November 21 at 8:30 PM SGT /November 21 at 11:30 PM AEST. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from PDD Holdings' Q3 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what management has to say!
Disclaimer:
This presentation i...

Global AI chip giant $NVIDIA (NVDA.US)$released its FY25 Q3 results after the US market closed on November 20, significantly exceeding market expectations. The company's revenue for this quarter was $35.1 billion, up 92% year-over-year, surpassing the consensus estimate of $33.25 billion. Non-GAAP EPS was $0.81, up 103% year-over-year, exceeding the consensus estimate of $0.74.
After the results were released, NVIDIA's stock price initi...